New Brunswick-based cannabis cultivator Organigram Holdings has temporarily laid off roughly 400 employees as a result of the COVID-19 pandemic, the company announced late Monday.

That represents about 45% of Organigram’s workforce.

The layoffs were made “primarily to help boost COVID-19 containment efforts” and the majority were voluntary, the company said in a press release.

Some workers, including those in “some administrative, support and other functions,” were laid off because they were considered non-essential in the short-term.

“During this temporary period, Organigram expects to be faced with cultivation, harvest, production and packaging reductions but will also plan to supplement with inventories on hand to meet anticipated demand,” said the press release.

Production of unspecified Organigram products with higher manual labor requirements will be deprioritized as the company focuses “on leveraging automated and the most efficient lines of production.”

The company had warned about anticipated new coronavirus layoffs in late March.

Organigram is not not the first major Canadian cannabis producer to lay off staff in recent months.

Hexo cut its workforce by about 200 last October, and about 500 jobs were lost when Canopy Growth closed major B.C. greenhouses in March.

Organigram is due to report its second quarter earnings on April 14.

Shares of Organigram are traded on the TSX and Nasdaq stock exchanges.

For more of Marijuana Business Daily’s ongoing coverage of the coronavirus pandemic and its effects on the cannabis industry, click here.

Pure Cannabis Hemp Oil

• Pure CBD Tincture, derived from organic, US-harvested hemp, lab-tested for quality.

• Clinically proven therapeutic effects.

• Relieves anxiety and stress

• Eliminates chronic pain and aches

• Regulates mood and sleep patterns

• Enhances focus and clarity
  
  
  

addiitional information, George Scorsis website
Originally posted on via Cannabis Industry News